SML2377

GSK′962

≥98% (HPLC)

• Synonym(e): 1-[(5R)-4,5-Dihydro-5-phenyl-1H-pyrazol-1-yl]-2,2-dimethyl-1-propanone; 2,2-Dimethyl-1-(5(R)-phenyl-4,5-dihydro-pyrazol-1-yl)-propan-1-one, GSK 962, GSK 963 inactive control, GSK 963 negative control, GSK′ 962A, GSK′962A, GSK′963 inactive control, GSK′963 negative control, GSK-962, GSK-962A, GSK962, GSK962A
• Empirische Formel (Hill-System): C₁₄H₁₈N₂O
• CAS-Nummer: 2049872-86-6
• Molekulargewicht: 230.31
• UNSPSC Code: 12352200
• NACRES: NA.77
• Assay: ≥98% (HPLC)
• Form: powder

Eigenschaften

• assay: ≥98% (HPLC)
• form: powder
• color: white to beige
• solubility: DMSO: 2 mg/mL, clear
• storage temp.: 2-8°C
• SMILES string: O=C(C(C)(C)C)N1[C@@H](C2=CC=CC=C2)CC=N1

Beschreibung

Biochem/physiol Actions

GSK′962 (GSK′962A) corresponds to the inactive (R)-enantiomer of the highly potent and selective RIPK1 (RIP1) inhibitor GSK′963 (GSK′963A). GSK′962 serves as an ideal GSK′963 negative control compound for probing RIPK1-mediated responses both in vitro and in vivo.

Inactive (R)-enantiomer and an ideal negative control of GSK′963 for probing RIPK1-mediated responses both in vitro and in vivo.

Sicherheitshinweise

• Lagerklasse: 11 - Combustible Solids
• Was ist los?: WGK 3
• Flammpunkt (°F): Not applicable
• Flammpunkt (°C): Not applicable